Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

by Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
Published 2020-05-01

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]

by Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
Published 2021-05-01

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

by Cohen J, Miles MC, Donohue JF, Ohar JA
Published 2016-04-01

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

by Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB
Published 2019-03-01

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies

by Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S
Published 2019-02-01

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

by Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM, Strange C
Published 2015-07-01